Muscular Dystrophy, Emery-Dreifuss

Explore clinical trials studying Muscular Dystrophy, Emery-Dreifuss. Study availability and eligibility vary by location and protocol.

3 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Muscular Dystrophy, Emery-Dreifuss trial results

Recruiting

NCT03058185

Conditions: Autosomal Emery-Dreifuss Muscular Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Emerinopathies, +11 more
Locations: Centre de référence maladies neuromusculaires,CHU d'Angers Angers, France

CHU Strasbourg Strasbourg, Bas-Rhin, France

CHU Marseille Marseille, Bouches-du-Rhône, France

CHU Caen Caen, Calvados, France

View all 28 locations

Recruiting

NCT01403402

Conditions: Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Fatty Liver and Infantile-onset Cataract Caused by TRAPPC11 Mutations), Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan and Epilepsy), Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan), +89 more
Locations: Congenital Muscle Disease International Registry (www.cmdir.org) Lakewood, California, United States

Completed

NCT05099107

Conditions: Centronuclear Myopathy, Congenital Myopathy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +17 more
Locations: Sahlgrenska university hospital Gothenburg, Västra Götaland County, Sweden